ContraVir Pharmaceuticals (CTRV) traded down $0.02 during trading on Monday, reaching $0.51. 278,199 shares of the company’s stock traded hands, compared to its average volume of 1,347,748.
ILLEGAL ACTIVITY WARNING: “ContraVir Pharmaceuticals Inc (CTRV) PT Set at $4.00 by Maxim Group” was posted by BBNS and is the property of of BBNS. If you are reading this article on another domain, it was illegally copied and republished in violation of U.S. & international copyright laws. The legal version of this article can be accessed at https://baseballnewssource.com/markets/contravir-pharmaceuticals-inc-ctrv-pt-set-at-4-00-by-maxim-group/1745094.html.
A hedge fund recently raised its stake in ContraVir Pharmaceuticals stock. Vanguard Group Inc. grew its position in shares of ContraVir Pharmaceuticals Inc (NASDAQ:CTRV) by 17.9% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 2,414,475 shares of the biopharmaceutical company’s stock after purchasing an additional 366,192 shares during the quarter. Vanguard Group Inc. owned about 3.79% of ContraVir Pharmaceuticals worth $1,400,000 as of its most recent SEC filing. 9.93% of the stock is owned by hedge funds and other institutional investors.
About ContraVir Pharmaceuticals
Receive News & Ratings for ContraVir Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ContraVir Pharmaceuticals Inc and related companies with our FREE daily email newsletter.